期刊文献+

槲皮素对大鼠胸主动脉不同节段的差异性舒张作用研究 被引量:1

下载PDF
导出
摘要 目的 探讨槲皮素(Quercetin)对大鼠离体胸主动脉不同节段的差异性舒张作用及其机制.方法 SD大鼠24只,常规方法制备离体胸主动脉血管环,用离体血管环张力记录仪进行实验,按血管段离开心脏的远近分为远心段、中段和近心段三组,每组再分为内皮完整组和去内皮组.将血管环用氯化钾(KCl,60 mmol/L)或苯肾上腺素(PE,浴槽终浓度10-5mol/L)预收缩后,用槲皮素再对其进行舒张,测定各组槲皮素对预收缩血管环的舒张作用并计算pEC50值.结果 槲皮素在10-6~10-4mol/L范围内对胸主动脉具有浓度依赖性的舒张效应,PE预收缩后,有内皮组近心段、中段和远心段胸主动脉都在10-4mol/L达到的最大舒张效果,舒张幅度分别为(68.20±3.70)%,(55.30±4.20)%,(50.40±2.60)%;去内皮组近心段、中段和远心段胸主动脉去内皮后其舒血管效应可分别达到(67.1±2.3)%,(53.4±4.5)%,(48.2±4.2)%.KCl预收缩后,有内皮组近心段、中段和远心段胸主动脉都在10-4M达到的最大舒张效果,舒张幅度分别为(82.20±6.30)%,(74.30± 5.10)%,(54.87 ± 5.20)%;槲皮素对各段内皮完整组和去内皮组舒张效果比较,差异均无统计学意义(P>0.05);槲皮素对内皮完整组远心段与近心段的舒张效果比较,差异有统计学意义(P<0.01).结论 槲皮素对高钾或苯肾预收缩的不同节段胸主动脉均有浓度依赖性的舒张效果,且表现为近心段舒张较中段和远心段强;槲皮素对胸主动脉不同节段的舒张作用不具有内皮依赖性,即其舒张血管效应不受内皮的影响.
出处 《中西医结合心脑血管病杂志》 2014年第3期341-342,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献4

  • 1Hertog MG,Feskens EJ,Kromhout D,et al.Dietary antioxidant flavonoids and risk of coronary heart disease:The Zutphen Elderly Study[J].Lancet,1993.342(8878):1007-1011.
  • 2Xue W,Zhang M,Li J,et al.Effects of taurine on aortic rings isolated from fructose-fed insulin resistance and normal rat aortic rings are different[J].Cardiovasc Drug Ther,2008,22:461-468.
  • 3Morales MA,Lozoya X.Calcium-antagonist effects of quercetin on aortic smooth muscle[J].Planta Med,1994,60(4):313-317.
  • 4Tanaka YK,Koike L,Toro MK.Channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms[J].J Smooth Muscle Research,2004,40(4,5):125-153.

同被引文献12

  • 1Tan B J, Liu Y, Chang K L, et al. Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer [J]. Int J Nanomedicine, 2012, 7: 651-661.
  • 2Tan Q, Liu W, Guo C, et al. Preparation and evaluation of QC-loaded lecithin -chitosan nanoparticles for topical delivery [J]. Int J Nanomedicine, 2011, 6: 1621-1630.
  • 3Li H, Zhao X, Ma Y, et al. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles [J]. J Control Release, 2009, 133(3): 238-244.
  • 4Sun M, Gao Y, Pei Y, et al. Development of nanosuspension formulation for oral delivery of quercetin [J]. J Biomed Nanotechnol, 2010, 6(4): 325-332.
  • 5Lan K, Zhang Y, Yang J, et al. Simple quality assessment approach for herbal extracts using high performance liquid chromatography-UV based metabolomics platform [J]. J Chromatogr A, 2010, 1217(8): 1414-1418.
  • 6Morand C, Crespy V, Manach C, et al. Plasma metabolites of quercetin and their antioxidant properties [J]. Am J Physiol, 1998, 275(1/2): 212-219.
  • 7Zhang Z, Feng S S. Self-assembled nanoparticles of poly(lactide)-Vitamin E TPGS copolymers for oral chemotherapy [J]. Int J Pharm, 2006, 324(2): 191-198.
  • 8Pan J, Feng S S. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles [J]. Biomaterials, 2008, 29(17): 2663-2672.
  • 9Wang G, Wang J J, Yang G Y, et al. Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death [J]. Int J Nanomedicine, 2012, 7: 271-280.
  • 10王刚,常明泉,杨光义,曾南,叶方.槲皮素长循环纳米脂质体的小鼠口服吸收研究[J].医药导报,2011,30(10):1266-1269. 被引量:8

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部